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Background: Physical activity is important for a healthy lifestyle. Although physical activity can delay complications
and decrease the burden of the disease, the level of activity of patients with chronic obstructive pulmonary disease
(COPD) or type 2 Diabetes Mellitus (DM2) is often far from optimal. To stimulate physical activity, a monitoring and
feedback tool, consisting of an accelerometer linked to a smart phone and webserver (It’s LiFe! tool), and a
counselling protocol for practice nurses in primary care was developed (the Self-management Support Program).
The main objective of this study is to measure the longitudinal effects of this counselling protocol and the added
value of using the tool.
Methods/Design: This three-armed cluster randomised controlled trial with 120 participants with COPD and 120
participants with DM2 (aged 40–70), compares the counselling protocol with and without the use of the tool
(group 1 and 2) with usual care (group 3). Recruitment takes place at GP practices in the southern regions of the
Netherlands. Randomisation takes place at the practice level. The intended sample (three arms of 8 practices)
powers the study to detect a 10-minute difference of moderate and intense physical activity per day between
groups 1 and 3. Participants in the intervention groups have to visit the practice nurse 3–4 times for physical activity
counselling, in a 4-6-month period. Specific activity goals tailored to the individual patient's preferences and needs
will be set. In addition, participants in group 1 will be instructed to use the tool in daily life. The primary outcome,
physical activity, will be measured in all groups with a physical activity monitor (PAM). Secondary outcomes are
quality of life, general - and exercise - self-efficacy, and health status. Follow-up will take place after 6 and 9 months.
Separately, a process evaluation will be conducted to explore reasons for trial non-participation, and the
intervention’s acceptability for participating patients and nurses.
Discussion: Results of this study will give insight into the effects of the It’s LiFe! monitoring and feedback tool
combined with care from a practice nurse for people with COPD or DM2 on physical activity.
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Because increased physical activity (PA) has positive effects
on prognosis and quality of life [1,2], stimulating PA is an
important element in the treatment of people with chronic
diseases such as chronic obstructive pulmonary disease
(COPD) or type II diabetes (DM2) [3,4]. It is, however,
a challenge to adhere to guidelines for healthy exercise
(at least 30 minutes of moderate activity five days a week)
[5,6]. By integrating PA counselling into routine practice,
primary care providers can support patients in meeting
this challenge [5,7]. In the Netherlands the majority of
chronically ill patients visit the family practice regularly to
monitor their condition, and it is the task of the practice
nurse (PN) to provide lifestyle counselling during those
consultations [8,9].
The most common method of PA promotion is verbal
advise, followed by print- and computer-based interven-
tions [10]. Interventions incorporating technology that is
readily accessible on a daily basis for monitoring activity
levels, such as computers or mobile phones, can support
care providers to coach patients in establishing behav-
ioural changes [11]. Those interventions may facilitate
long-term follow-up [12,13], and may be an effective way
to provide PA counselling without increasing the time de-
mands on primary care providers [14].
PA counselling has the potential to increase PA levels
in the short term [13]. However, evidence regarding
which methods of exercise promotion works best in the
long term is still limited [15]. Furthermore, computer-
based patient self-management programs, delivered in
health-supported settings, show the potential for chan-
ging health behaviours and improving clinical out-
comes, but more well designed trials are warranted to
test their effectiveness [16]. Those trials should espe-
cially focus on the effects of theory-based intervention
development, combined with the effect of tailored advise
and feedback [17].
We therefore, developed and tested a monitoring
and feedback tool called It’s LiFe! [18,19] and a corre-
sponding counselling program for primary care nurses
(the Self-management Support Program). The basic
ideas behind this combination are: providing an objective
measurement of PA via an accelerometer, collaborative
goal setting and automatic feedback via an application on
a smartphone combined with PA counselling by the PN.
Results from a feasibility study showed that participants
were positive about the tool. Regarding the effects of using
the tool, a positive trend was seen: the mean level of PA
increased by more than 10 minutes per day and patients
reported a higher quality of life [20].
This paper describes the study protocol of a three-armed
cluster randomised controlled trial with 120 participants
with COPD and 120 participants with DM2 (aged 40–70),
comparing the Self-management Support Program withand without the use of the tool (group 1 and 2) with usual
care (group 3).
Objectives and hypotheses
The objective of this randomised controlled trial is to evalu-
ate the longitudinal effects of the It’s LiFe! tool embedded
in a Self-management Support Program (SSP) on 40–70
years old patients with COPD and DM2 in primary
care. The primary outcome measure is PA in daily life.
Secondary outcome measures are self-efficacy, quality
of life and health status. The main difference that is
evaluated is between the whole intervention and usual
care. Additionally, the isolated effect of the tool is
evaluated. Apart from the effect evaluation, a process
evaluation will be performed, aimed at getting insight
into the adherence to the intervention and the accep-
tance of the intervention by participating patients and
PNs.
The main hypothesis is that the whole intervention
will increase PA on a moderate level by at least 10 minutes
per day, over a four to six-month period, and to maintain
this increase over three months.
Methods/design
This paper was written according to the CONSORT 2010
statement: extension to cluster randomised trials [21].
Study design
The study is designed as a cluster randomised controlled
trial with GP practices as the unit of randomisation. To
compare the whole intervention with both usual care
and SSP only (to isolate the effect of the tool), the trial has
three arms: the use of a monitoring and feedback tool em-
bedded in the SSP (group 1), the SSP without the tool
(group 2), and usual care (group 3). The CONSORT flow-
chart (Figure 1) summarises the trial design. The popula-
tion consists of 120 participants with COPD and 120
participants with DM2 from 24 GP practices. Each prac-
tice provides 5 COPD patients and 5 DM2 patients, which
makes a total of 40 patients with COPD and 40 patients
with DM2 from 8 practices per trial arm.
Eligibility
Participants between 40 and 70 years old are eligible
when they are diagnosed with COPD or DM2, are treated
in primary care, and in the opinion of the PN, do not
comply with the Dutch Norm for Healthy Exercise [22].
Additional inclusion criteria for the DM2 patients are a
BMI > 25 and for the COPD patients: a clinical diagnosis
of COPD according to the GOLD-criteria stage 1–3, being
at least six weeks respiratory stable and on a stable drug
regimen. Furthermore, patients should have access to a
computer with an internet connection.
Assessed for eligibility (n=250 practices) 
Randomised (24 practicesin 2 blocks)
Assessed for eligibility±540participants 
Allocated to group 1  
Tool and SSP
(N=8 practices) 
Received allocated intervention 
(n=potential 80  
participants).
Did not receive allocated 
intervention 
(n= XX participants).
Will give reasons.
Allocated to group 2  
SSP
(N= 8 practices)
Received allocated intervention 
(n= potential 80 
participants).
Did not receive allocated 
intervention 
(n= XX participants).
Will give reasons.
Allocated to group 3 
Care as usual
(N= 8 practices)
Received allocated intervention 
(n=potential 80 
participants).
Did not receive allocated 
intervention 
(n= XX participants).
Will give reasons.
Enrolment
Allocation
Follow-up
Lost to follow-up 
(n=o practices; potential XX 
participants did not 
respond).
Discontinued intervention 
(n=0 practices; potential XX 
participants).
Will give reasons.
Analysis
Analysed 
(n=8 practices; potential 80 
participants).
Excluded from analysis 
(n=0 practices; potential XX 
participants).
Will give reasons.
Lost to follow-up 
(n=o practices; potential XX 
participants did not 
respond).
Discontinued intervention 
(n=0 practices; potential XX 
participants).
Will give reasons.
Lost to follow-up 
(n=o practices; potential XX 
participants did not 
respond).
Discontinued intervention 
(n=0 practices; potential XX 
participants).
Will give reasons.
Analysed 
(n=8 practices; potential 80  
participants).
Excluded from analysis 
(n=0 practices; potential XX 
participants).
Will give reasons.
Analysed 
(n=8 practices; potential 80  
participants).
Excluded from analysis 
(n=0 practices; potential XX 
participants).
Will give reasons.
Excluded 
(n=0)
Refused to participate
(n=226 practices)
Figure 1 CONSORT flowchart trial design; potential flow of participants.
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tions with a low survival rate, severe psychiatric illness
or chronic disorders or diseases that seriously influence
the ability to be physically active and those being pri-
marily treated by a medical specialist or participating in
another PA intervention, as well as patients with insuffi-
cient mastery of the Dutch language.Recruitment
Recruitment of practices
GP practices located in southern regions of the Netherlands
will be approached by an invitation letter, by telephone
and personal contact with GP’s, practice managers, and
PNs, to invite them to participate in the study, until a
maximum of 24 practices is reached. On the basis of the
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practices will be categorised into small (<90), medium
(90–190), large (190–390) and extra-large (>390).
Recruitment of participants
To recruit participants for the study, PNs will identify
20–32 eligible patients per practice, who fulfil the inclu-
sion criteria. This will be done before the randomisation
of the practices. When the PN considers a patient eligible
for participation, the nurse will send a recruitment letter
to the patient with general information about all groups.
After the randomisation, the PN will call those patients to
give specific information about the group in which the
practice is allocated and to ask patients if they want to
participate; non-responders will be asked for their reasons
not to participate. Each general practice will be instructed
to include 10–14 participants, with an equal distribution
of COPD and DM2 patients. When the patient decides to
participate, he or she will receive an informational let-
ter and informed consent form.
Randomisation procedure
A total of 24 practices will be randomly allocated into the
three groups in two blocks of twelve practices. Before ran-
domisation, the practices will be pre-stratified into four
strata based on the size of the practice. The practices will
be stratified into groups of 3 per size and randomised by
an independent person into either one of the two inter-
vention groups or the control group by numbering sealed
envelopes which contain the names of the practices.
As they have to contact participating nurses to inform
them about the relevant intervention, the executing re-
searchers (SvdW & RV) will be aware of which practices
are in which group. Patient data will be analysed anonym-
ously, without any recognition of names or practices. An
independent person will store the coding key. All cleaning
and processing of data will be carried out on the whole
database (i.e., all three groups). The group and practice
variable will only be revealed at the end of the study.
Intervention
The different components of the interventions are sum-
marised in Figure 2.
The interventions have been designed in a user-centred
manner; two patient representatives, from the Netherlands
Asthma Foundation and the Dutch Diabetes Association,
participated in the research group to provide feedback on
every aspect of the project.
The tool (Group 1)
The It’s LiFe! tool (Figure 3) consists of an accelerometer, a
smartphone app, and a server/web application. Participants
receive personalised feedback on the smartphone concern-
ing their amount of activity in relation to an activity goal,which is set in dialog with their PN [18] after a two week
pre-measurement period. Nurses can monitor patients’ PA
via a secure website [19].
The use of the tool starts when the participant is regis-
tered on the server by the PN. The server has two por-
tals, one for care providers (It’s LiFe! monitor) and one
for patients (It’s LiFe! online). The PN creates an account
for the participant and then the log-in name and password
are sent by email. At home, the participant has to complete
a short questionnaire online (a dialog session) concerning
PA preferences and has to log in on the phone. Daily at
1 a.m. the smartphone automatically connects to the
server to upload the PA data from the previous day.
There is a pre-measurement period of 14 days. Participants
can enter “remarks of the day” whenever they want, such as
comments about being sick or having forgotten to wear the
meter. In the second week, they receive dialog sessions
about the enjoyment and exertion of performed activities.
Furthermore, participants receive two sessions from the
server concerning barriers and facilitators and activity
planning based on the Physician-based Assessment and
Counselling for Exercise intervention (PACE) [23], with
the aim of modifying factors known to influence PA,
such as social support and self-efficacy. After two weeks,
together the patient and nurse set a goal in minutes of ac-
tivity per day, which is entered into the system by the nurse.
Based on the PA data related to this goal, participants
receive feedback sessions. There are several types of
messages (e.g., tips, encouragement, positive trend,
reward, barriers, facilitators and the suggestion to adjust
goals). Participants will get such messages when they
reach their goal after 3, 5 and 14 days or when they do
not reach their target after 3, 5 and 14 days. In some
cases, the goals have to be reached 100 % and others are
based on 80 % achievement. All messages are written in
a positive tone, e.g., ‘Good that you still try to be more
active. We can see that it is hard to reach your daily
target. If you want to adjust your goal, contact your care
provider or click here’.
Instruction tool
The PNs in group 1 practices will receive a personal
account for the monitor, a manual and the researchers
(SvdW & RV) will instruct PNs on how to use the system.
Researchers (SvdW & RV) will also advise the nurses to try
out the tool themselves and to sign up as a patient in the
system to get familiar with it. In addition to a manual, there
are several short instructional films available on a special
website (see http://www.maastrichtuniversity.nl/web/show/
id=6637066/langid=43); the films cover a variety of topics,
for example, how to log on to the app and how to respond
to a session. For technical questions about the use of the
tool, participating patients and PNs are able to contact a
helpdesk during working hours.
Figure 3 The It’s LiFe! tool.
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Figure 2 Interventions RCT It’s LiFe!
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Table 1 Details of the tool and the PA counselling
consultations and proposed Behavioural Change
Techniques [29]
Condition 1: Tool
Proposed Behavioural
Change Techniques (BCT)
Number according
to BCT Taxonomy
Abraham and Michie
Tool widget
(continuous)
Prompt specific goal setting 10
Provide feedback on
performance
13
Prompt review of
behavioural goals
11
Tool sessions Provide general encouragement 6
Provide general information 1
Provide information
on consequences
2
Prompt intention formation 4
Plan social support/social
change
20
Prompt barrier identification 5
Condition 1 and 2: Self-management Support Programme
Consultation 1 Provide general information 1
Motivational interviewing 24
Provide general encouragement 6
Provide information
on consequences
2
Prompt intention formation 4
Consultation 2 Provide general
encouragement
6
Motivational interviewing 24
Prompt specific goal setting 10
Plan social support/social
change
20
Consultation 3 Provide general encouragement 6
Provide feedback
on performance
13
Motivational interviewing 24
Prompt review of
behavioural goals
11
Prompt barrier identification 5
Relapse prevention 23
Consultation 4 Provide general encouragement 6
Provide feedback
on performance
13
Motivational interviewing 24
Prompt review of
behavioural goals
11
Prompt barrier identification 5
Relapse prevention 23
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The intervention in group 1 consists of the use of the
tool in daily living, intertwined with consultations with
the PN – the Self-Management Support Program (SSP).
The intervention in group 2 consists of this program
without the use of the tool. The program is based on the
Five A’s model (Assess, Advise, Agree, Assist, Arrange),
a counselling protocol to support self-management in a
primary care setting [24,25].
This program consists of four consultations with the PN:
in the first week, after 2 weeks, after 8–12 weeks and after
16–24 weeks. Before the consultations, the participants re-
ceive an informational booklet about the course of the
intervention containing the Short Questionnaire to Assess
Health-enhancing PA (SQUASH) [26] and a list of locally
organised PA options. The duration of the consultations is
20 minutes, or a 10-minute extension of a regular consult-
ation. In the first consultation, the PN will try to increase
awareness of the PA pattern of the patient, and inform the
patient about the health risks related to a sedentary life-
style. The patient and the PN will get an idea about the
PA level of the patient by discussing the previously com-
pleted SQUASH questionnaire. Furthermore, the patient
gets a leaflet with disease specific information related to
PA [27,28].
During the second consultation, a goal will be set re-
garding physical activity in minutes per day, based on
the results of the measurements of the first two weeks
(pre-measurement). The pre-measurement in group 1 is
an objective measurement based on the tool, in group 2 this
is a subjective measure achieved by asking participants to
keep a PA diary. The results of the pre-measurement of
group 1 are visible for the nurse on the monitor portal of
the It’s LiFe! server. In both intervention groups, the nurse
will encourage the patient to focus on goals that fit the
patient’s preferences and to set up a Specific, Measureable,
Attainable, Realistic, and Timely (SMART) plan to reach
personal goals, and the nurse will inform the participant
about locally organised exercise opportunities.
In the third consultation, possibly by mail or telephone,
the nurse will discuss the results, barriers and facilitators
related to PA. In the last consultation, the nurse will dis-
cuss the results, behaviour change(s) and habits with the
participant. The proposed behaviour change counselling
techniques have been classified according to Abraham
and Michie’s taxonomy as listed in Table 1 [29].
Instruction for SSP
Informational booklets are produced, focusing on PA
behaviour change, with an explanation and a timeline
of the intervention. Before the start of the intervention,
these booklets will be sent to participants.
The nurses in group 1 and 2 practices will receive a
personal instruction at their workplace; these instructions
Verwey et al. BMC Family Practice 2014, 15:93 Page 7 of 10
http://www.biomedcentral.com/1471-2296/15/93will also be available as an online web lecture. The nurses
will receive an information file with detailed instruction
charts for the course of each consultation, and an explan-
ation of the intended counselling techniques.
Care as usual (group 3)
Care as usual (for all three groups) consists of regular con-
sultations with the PN (COPD patients have 1–2 consulta-
tions and DM2 patients have 4 consultations per year).
Participants in the usual care group will not be offered any
programme besides usual contacts with the GP and PN.
Data collection
All participants are asked (by a letter from the researchers)
to wear the PAM and complete questionnaires at three
different time points; namely at baseline (t0), at the end of
the intervention after 4–6 months (t1), and at follow-up,
3 months after the end of the intervention (t2). Measure-
ments and time points are summarised in Table 2.
Outcome parameters
Primary outcome measure
Physical activity PA will be measured with the Personal
Activity Monitor (PAM AM300) [30]. The PAM is a
small tri-axial accelerometer that can be easily attached
to a belt and is worn on the hip. The PAM registers all
hip movements that are made during a day. Via a dock-
ing station, and connection to the internet, the PAM
scores and data of minutes a day in a sedentary category
(<1.8 METS), a living category (1.8-3 METS), a moderate
category (3–6 METS), and a vigorous category (>6 METS)
will be uploaded [30]. The number of minutes of PA in
the moderate and vigorous category (>3 METS) will be
considered as the primary outcome measure. We will also
report about the number of minutes of PA in the living,
moderate and vigorous category >1.8 METS. These
measures indicate all types of activity during the day.Table 2 Measurements and time points
Concept (questionnaires) Intervention groups Control group
t0 t1 t2 t0 t1 t2
Demographic variables x x
Physical activity (PAM) x x x x x x
Quality of life (SF 36) x x x x x x
General Self-Efficacy (GSS) x x x x x x
Exercise Self-Efficacy (ESS) x x x x x x
Health status (DSC-R or CRQ-SAS) x x x x x x
Process evaluation x
PAM: Personal Activity Monitor.
DSC-R: Diabetes Symptom Checklist-Revised.
CRQ-SAS: Chronic Respiratory Questionnaire-Self-Administered Standardised.
T0 - baseline.
T1 - after 4–6 months (end of intervention).
T2 - after 9 months (post intervention).The possibility for the users of noticing their activity
scores on the PAM will be deactivated; the displays will
only show a digital clock. Participants will be asked to
wear the PAM during 8 consecutive days for more than
12 hours a day. They will be asked to register the days and
times that they wear the PAM; activities that are difficult
to measure (swimming, cycling and strength training)
will be recorded on a paper log. A measurement will be
considered valid if the wear time is > 8 hours per day and
if there is data of > 5 days.
Secondary outcome measures
Quality of life To measure the quality of life the SF-36
will be used [31,32]. The SF-36 consists of 36 items,
organised into 8 subscales, including vitality, physical
functioning, body pain, general health perceptions, emo-
tional role functioning, social role functioning, and mental
health. A higher score indicates a better quality of life.
Self-efficacy An important mediator of PA behaviour is
self-efficacy; therefore this will be measured with two
different questionnaires. The 10-item General Self-efficacy
Scale (GSS) is designed to assess optimistic self-beliefs to
cope with a variety of difficult demands in life, scores for
each item range from 1 (totally disagree) to 4 (totally agree)
[33]. The Exercise Self-efficacy Scale (ESS) describes 18
situations during which it could be difficult to adhere to
an exercise routine, for example ‘without support from
family and friends’. Participants are asked to rate their
degree of confidence to continue with regular exercise
in the listed situations. The ESS uses a 100-point scale
for each item, ranging from 0 ‘I cannot do this at all’ to 100
‘I am certain that I can do it’, with higher scores reflecting
higher levels of exercise self-efficacy [34-36].
Additional measures
Health status Personal reported health status will be
measured by two disease specific questionnaires, the
Diabetes Symptom checklist-revised (DSC-R) for partici-
pants with DM2 and the Chronic Respiratory Questionnaire
(CRQ) for participants with COPD.
DSC-R consists of 34 items and 8 sub-dimensions;
hyperglycaemia, hypoglycaemia, psychological – cognitive,
psychological – fatigue, cardiovascular, neurological –pain,
neurological – sensoric and ophtalmological. On the
DSC-R, patients indicate for each of the 34 listed symp-
toms whether or not they suffered from it in the last
month. If they did experience the symptom, patients
rate the perceived burden on a scale from 1 (not at all)
to 5 (extremely) [37-39].
The Chronic Respiratory Questionnaire (CRQ-SAS)
consists of 20 items across four dimensions: dyspnoea,
fatigue, emotional function, and mastery (the patient’s
feeling of control over their disease). The dyspnoea
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asked to select the 5 activities associated with breathless-
ness that they perform frequently and are most important
to them. Dyspnoea items can be selected from a list of 26
suggested items or may be written in by the patients.
Items are scored from 1 (most severe) to 7 (no impair-
ment) [40,41].
Process evaluation Because of the expected wide range
of differences in the performance of the intervention by
the PNs and in the adherence of patients in using the
tool, a process evaluation is necessary [42,43]. The purpose
of the process evaluation is to examine the context, imple-
mentation and receipt of the intervention. The evaluation
consists of registration forms, a process evaluation ques-
tionnaire for participants in the intervention groups at t1,
interviews by telephone with the PNs responsible for the
study and focus groups with PNs at the end of the study.
During the interviews, information is gathered about the
inclusion of participants, the course of the consultations,
the education and motivation of the PNs, experienced mo-
tivation and treatment possibilities of the participants and
the perceived effect of the intervention. Time spent on the
intervention is recorded on registration forms. In the ques-
tionnaires, participants in both groups and the PNs are
asked about their experiences with the SSP and the tool. In
Additional file 1 all process evaluation components, opera-
tionalisation, and measurements are summarised, according
to the framework of Saunders [44].
Sample size and power calculation For this study, 240
patients are required, with a minimum of 80 participants
per group. Based on a validation study, we assume that
the PA level of participants is an average of 24 minutes
with a range of 14.6 minutes. A mean difference between
group 1 and group 3 of ten minutes (42 %) of moderate
to vigorous PA spent per day will be seen as clinically
relevant. While assuming an intra-class correlation of
10 % based on practice, to account for the dependency
of the data, with a power of 80 % and a significance level
of 0.05, a total of 72 patients over 8 general practices
are required in each group. Because a drop-out rate of
10 % is expected, practices will be asked to include 8–14
patients per practice in each subgroup, depending on
the size of the practice.
Planned statistical analyses
Descriptive statistics
Demographic data (e.g., age, gender, disease, co-morbidities)
will be described for the total group and for the subgroups
separately. Continuous variables will be denoted with
means, standard deviations, and medians. Categorical
variables will be denoted in numbers and percentages.
The participants included in the 3 arms will be testedon differences between characteristics, with chi-square,
ANOVA (Kruskal Wallis).
If variables differ between groups, with a p-value ≤0.10,
they will be considered to be potential confounders in
further analysis.
Data analysis for primary and secondary outcomes
An intention to treat analysis and a per protocol analysis
will be conducted. For each outcome measure (all outcomes
are continuous) data will be expressed as mean +/−SD. The
between group comparisons will be analysed with multilevel
analysis to account for the dependency of observations. We
will apply a 3 level linear mixed model (time, participant,
practice); the level of statistical significance will be set at
0.05 (two-tailed). Separate models (random intercept) will
be set up for each outcome measure. The independent
variables in each model are two dummy variables indicat-
ing the group, with the group of patients receiving usual
care as the reference category and two dummy variables
for time and their interaction effects. In addition, an extra
dummy variable will be included to indicate the patient
group (COPD versus DM2), to study whether the effects
in COPD patients differ from the effects in patients with
DM2. If needed, additional baseline variables will be in-
cluded to account for possible confounding. If normality
assumptions are violated, outcome variables will be log-
transformed and if necessary non-parametric tests will
be used. SPSS, version 19 and Mlwin, version 2.02 will
be used to analyse the data.
Data analysis process evaluation
Quantitative data will be analysed by means of descriptive
statistics. In order to identify relevant themes, qualitative
data (results of open-ended interviews and focus groups)
will be independently analysed by two researchers
using NViVo version 9. A concurrent triangulation
strategy will be applied to confirm, cross validate and
corroborate the findings.
Procedure for accounting for missing, unused and
unexpected data
Accounting for missing values on items in questionnaires
will be handled according to the scoring algorithms of the
questionnaires. Missing variables in follow-up data will not
be imputed since it has been shown that multilevel analysis
is a very flexible method for handling missing data [45].
Stopping rules
There are no formal statistical stopping rules. If a patient
decides to withdraw (e.g., hospital admission), the nurse
may discontinue the intervention, but all participants
will be asked to complete follow-up assessments. Patients
can withdraw from the study at any time.
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The study protocol was approved by the research ethics
committee of azM/UM, Maastricht, the Netherlands in
2013 (METC12-3-071).
Discussion
This study fills a gap in the literature about how to im-
prove self-management of patients with COPD or DM2
in increasing their level of PA by using technology em-
bedded in primary care.
Post-recruitment selection bias, a well-known problem
of cluster randomised controlled trials, will be partly
avoided by asking the nurses to include patients and
send a general invitation letter before the randomisation
of the practices. But not informing the patients about
the intended intervention (the randomisation outcome
of their GP practice), is insuperable because patients
have to be informed about the intervention before they
agree to participate.
During a pragmatic trial, which aims to measure the
effectiveness of an intervention in routine practice, it is
important to collect process data to avoid Type III er-
rors (evaluating an intervention that was inadequately
implemented). In choosing the outcomes and measure-
ments of the process evaluation, the potential for in-
creased Hawthorne effects will be taken into account
by minimising the contacts between researchers and
participants, and by avoiding overlapping roles be-
tween researchers and PNs, for example by asking the
PNs to include patients for the study, and by arranging
an independent helpdesk. Patients will not be interviewed
during the intervention in order to distinguish between
the intervention and its evaluation.
Conclusion
In conclusion, the need to increase the level of PA in people
with COPD or DM2 is evident, in which the use of a moni-
toring and feedback tool embedded in a counselling proto-
col can play an important role. In the present three-arm
cluster randomised controlled trial, we will evaluate the ef-
fectiveness of this counselling protocol and the added value
of using the It’s LiFe! monitoring and feedback tool.
Additional file
Additional file 1: Components, operationalisation and
measurements process evaluation.
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